| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 118.57▼ | 119.76▼ | 119.37▼ | 118.76▼ | 118.42▲ |
| MA10 | 119.31▼ | 119.77▼ | 119.59▼ | 120.41▼ | 116.09▲ |
| MA20 | 120.15▼ | 119.62▼ | 118.89▼ | 119.11▼ | 114.58▲ |
| MA50 | 119.99▼ | 119.01▼ | 119.73▼ | 115.67▲ | 106.83▲ |
| MA100 | 119.83▼ | 120.00▼ | 120.15▼ | 114.06▲ | 91.43▲ |
| MA200 | 119.00▼ | 119.97▼ | 116.90▲ | 109.82▲ | 82.23▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.285▼ | -0.127▼ | 0.070▲ | -0.401▼ | 0.055▲ |
| RSI | 35.341▼ | 44.221▼ | 45.288▼ | 51.780▲ | 58.189▲ |
| STOCH | 9.219▼ | 74.328 | 62.944 | 32.139 | 59.120 |
| WILL %R | -87.945▼ | -43.433 | -43.433 | -58.453 | -37.895 |
| CCI | -91.893 | -139.873▼ | -62.215 | -76.904 | 58.353 |
|
Friday, October 31, 2025 07:01 AM
US anti-virals giant Gilead Sciences late yesterday announced its third quarter 2025 results of operations, reporting total revenues increased 3% to $7.8 billion compared to the same period in 2024, ...
|
|
Friday, October 31, 2025 06:46 AM
Total product sales -- $7.3 billion in fiscal Q3 2025, up 4% sequentially from Q2 2025, with growth driven by the HIV portfolio and partially offset by lower oncology revenue; year-over-year, total ...
|
|
Friday, October 31, 2025 05:13 AM
Gilead Sciences, Inc. (Nasdaq: GILD) today announced it has been awarded the prestigious 2025 Prix Galien USA Award for Best Pharmaceutical Product for Yeztugo® (lenacapavir), the company’s ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/10/25 | 116.09 | 121.835 | 114.14 | 118.49 | 4,920,765 |
| 30/10/25 | 118.80 | 120.52 | 117.52 | 118.44 | 8,342,600 |
| 29/10/25 | 117.12 | 118.96 | 116.70 | 118.50 | 6,030,200 |
| 28/10/25 | 119.77 | 120.28 | 117.79 | 117.88 | 4,706,951 |
| 27/10/25 | 121.49 | 121.58 | 119.50 | 120.47 | 4,752,000 |
| 24/10/25 | 120.42 | 121.15 | 118.71 | 120.94 | 5,438,600 |
| 23/10/25 | 121.75 | 121.88 | 119.45 | 120.74 | 4,634,400 |
| 22/10/25 | 124.24 | 124.45 | 121.30 | 121.46 | 5,432,700 |
| 21/10/25 | 123.3804 | 124.61 | 121.92 | 124.08 | 5,512,771 |
| 20/10/25 | 122.59 | 123.99 | 122.20 | 123.11 | 8,149,500 |
|
|
||||
|
|
||||
|
|